# NSCLC_survivalPrediction
Diagnosis and Prognostic Analysis of Lung Cancer Based on Radiomics and Clinical Information

# Object：
CT radiomics can predict response to anti-PD-1 or anti-PD-L1 immunotherapy and clinical outcomes in non-small cell lung cancer （NSCLC）?

# 参考文献：
1. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. [Link](https://www.thelancet.com/journals/landig/article/PIIS2589-7500(23)00082-1/fulltext)
2. A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC. [Link](https://www.sciencedirect.com/science/article/pii/S1556086423000965)
